TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SRRK

Scholar Rock Holding Corp

Healthcare · Biotechnology

48.60$ -2.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SRRK
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
86.9% 96.0% 98.1% 94.3% 88.7% 87.1% 91.6% 92.7% 95.0% 95.3%
30.6% 91.6% 63.5% 18.5% 41.3% 69.9% 28.8% 32.7% 37.5% 80.0%
85.5% 94.0% 96.9% 80.2% 87.8% 83.1% 88.0% 90.0% 92.1% 90.9%
0.3% – – 12.7% 0.0% – 0.8% 0.3% 0.5% –
– – – -12.7% – – -0.8% – – –
7.4% 3.5% 1.8% 4.4% 2.1% 3.1% 2.1% – – –
– – – – – – – 1.3% 0.5% –
191.6% 186.8% 41.2% 42.5% 32.8% 43.5% 27.3% 27.6% 22.4% 39.3%
9.2% 8.2% 17.2% 16.7% 11.0% 21.1% 10.2% 10.5% 9.9% 13.7%
2.0% 1.0% 0.2% 0.6% 1.4% 5.4% 2.2% 2.8% 1.2% 1.4%
2.0% 2.2% 1.8% 0.6% 0.9% 1.5% 1.1% 1.1% 2.1% 2.5%
3.1% 0.6% 0.0% 0.0% 6.4% 15.9% 13.9% 15.7% 10.6% 24.7%
-91.6% -86.8% 58.8% 57.5% 67.2% 56.5% 72.7% 72.4% 77.6% 60.7%
-99.2% -93.3% -58.9% -80.4% -62.9% -123.5% -142.6% -217.5% -194.3% -321.7%
54.6% 29.0% 8.6% 14.0% 7.9% 12.1% 16.6% 24.4% 21.0% 28.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?